MAST CELL ACTIVATION DISORDER IDIOPATHIC

Clinical trials for MAST CELL ACTIVATION DISORDER IDIOPATHIC explained in plain language.

Never miss a new study

Get alerted when new MAST CELL ACTIVATION DISORDER IDIOPATHIC trials appear

Sign up with your email to follow new studies for MAST CELL ACTIVATION DISORDER IDIOPATHIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

New drug FSD201 tested for mysterious chronic pain condition

Symptom relief Terminated

This study tested whether FSD201 can reduce daily pain in adults with chronic widespread pain caused by idiopathic mast cell activation syndrome (MCAS). Only 2 people enrolled before the study ended early. Participants took FSD201 or a placebo for 56 days, and pain was measured u…

Matched conditions: MAST CELL ACTIVATION DISORDER IDIOPATHIC

Phase: PHASE2 • Sponsor: Quantum Biopharma • Aim: Symptom relief

Last updated May 26, 2026 04:27 UTC

MAST CELL ACTIVATION DISORDER IDIOPATHIC

Get alerted when new MAST CELL ACTIVATION DISORDER IDIOPATHIC trials appear

New drug FSD201 tested for mysterious chronic pain condition